Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Peri-Operative Tinzaparin in Colorectal Cancer
NCT01455831Phase 3Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Sep 2011
- Primary completion
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of tinzaparin in colorectal cancer (CRC), sponsored by Ottawa Hospital Research Institute. Started Sep 2011; status: completed.
02
Drugs
tinzaparin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01455831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01455831.